Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Experimental & Molecular Medicine|January 6, 2018
Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathwayZhong Xu, Junjie Hu, Hui Cao, et al.
Oncotarget|January 23, 2016
Comparison of liver oncogenic potential among human RAS isoformsSook In Chung, Hyuk Moon, Hye-Lim Ju, et al.
The Journal of Clinical Investigation|July 17, 2012
Cholangiocarcinomas can originate from hepatocytes in miceBiao Fan, Yann Malato, Diego F Calvisi, et al.
Journal of Hepatology|May 24, 2012
Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathwaysChunmei Wang, Salvatore Delogu, Coral Ho, et al.
Breast Cancer Research and Treatment|April 17, 2014
RANK expression as a prognostic and predictive marker in breast cancerBerit Maria Pfitzner, Daniel Branstetter, Sibylle Loibl, et al.
International Journal of Molecular Sciences|September 27, 2016
The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat ModelsSilvia Ribback, Verena Sailer, Enrico Böhning, et al.
Oncotarget|December 25, 2014
SKP2 cooperates with N-Ras or AKT to induce liver tumor development in miceSalvatore Delogu, Chunmei Wang, Antonio Cigliano, et al.
Pageof 12